Russian breast cancer study maps gene mutations and Real-World care

NCT ID NCT05939128

First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 23 times

Summary

This study looks at 625 people in Russia with high-risk early breast cancer to find out how common BRCA1/2 gene mutations are and what treatments they receive. Participants are already diagnosed and treated, and researchers will collect data from medical records and genetic tests. The goal is to learn more about current care patterns, not to test a new drug.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Arkhangelsk, Russia

  • Research Site

    Barnaul, Russia

  • Research Site

    Belgorod, Russia

  • Research Site

    Chelyabinsk, Russia

  • Research Site

    Grozny, Russia

  • Research Site

    Irkutsk, Russia

  • Research Site

    Khanty-Mansiysk, Russia

  • Research Site

    Krasnodar, Russia

  • Research Site

    Krasnoyarsk, Russia

  • Research Site

    Moscow, Russia

  • Research Site

    Nal'chik, Russia

  • Research Site

    Nyzhny Novgorod, Russia

  • Research Site

    Ryazan, Russia

  • Research Site

    Saint Petersburg, Russia

  • Research Site

    Severodvinsk, Russia

  • Research Site

    Sochi, Russia

  • Research Site

    Ufa, Russia

  • Research Site

    Vladivostok, Russia

  • Research Site

    Yaroslavl, Russia

Conditions

Explore the condition pages connected to this study.